Terms: = Prostate cancer AND SND1, Q7KZF4, TDRD11, p100, ENSG00000197157, 27044 AND Prognosis
2 results:
1. Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression.
Ngollo M; Lebert A; Daures M; Judes G; Rifai K; Dubois L; Kemeny JL; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D
BMC Cancer; 2017 Apr; 17(1):261. PubMed ID: 28403887
[TBL] [Abstract] [Full Text] [Related]
2. RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicity.
Xu Y; Josson S; Fang F; Oberley TD; St Clair DK; Wan XS; Sun Y; Bakthavatchalu V; Muthuswamy A; St Clair WH
Cancer Res; 2009 Apr; 69(8):3267-71. PubMed ID: 19351823
[TBL] [Abstract] [Full Text] [Related]
